Lyra Therapeutics (LYRA) Short Interest Ratio & Short Volume $8.53 +0.05 (+0.59%) Closing price 04:00 PM EasternExtended Trading$8.50 -0.03 (-0.35%) As of 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lyra Therapeutics Short Interest DataLyra Therapeutics (LYRA) has a short interest of 123,900 shares, representing 7.74% of the float (the number of shares available for trading by the public). This marks a 8.88% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 192,383 shares to cover all short positions.Current Short Interest123,900 sharesPrevious Short Interest113,800 sharesChange Vs. Previous Month+8.88%Dollar Volume Sold Short$1.11 millionShort Interest Ratio0.2 Days to CoverLast Record DateJune 30, 2025Outstanding Shares1,325,000 sharesFloat Size1,600,000 sharesShort Percent of Float7.74%Today's Trading Volume35,986 sharesAverage Trading Volume192,383 sharesToday's Volume Vs. Average19% Short Selling Lyra Therapeutics? Sign up to receive the latest short interest report for Lyra Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLYRA Short Interest Over TimeLYRA Days to Cover Over TimeLYRA Percentage of Float Shorted Over Time Lyra Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2025123,900 shares $1.11 million +8.9%7.7%0.2 $8.96 6/15/2025113,800 shares $1.29 million +37.9%8.6%0.2 $11.34 5/31/202582,500 shares $386.10 thousand -43.7%7.4%0.1 $4.68 5/15/2025146,600 shares $16.54 thousand -94.6%13.1%2.3 $0.11 4/30/20252,700,000 shares $320.76 thousand +21.6%N/A1.5 $0.12 4/15/20252,220,000 shares $204.68 thousand -7.9%3.6%1.9 $0.09 3/31/20252,410,000 shares $304.38 thousand +0.4%3.9%2.2 $0.13 3/15/20252,400,000 shares $412.80 thousand +27.7%3.8%2 $0.17 2/28/20251,880,000 shares $402.32 thousand -13.4%3.0%1.5 $0.21 2/15/20252,170,000 shares $451.79 thousand +1.4%3.5%1.5 $0.21 Get the Latest News and Ratings for LYRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20252,140,000 shares $391.19 thousand +0.5%N/A1.2 $0.18 1/15/20252,130,000 shares $402.57 thousand +1.4%N/A1.1 $0.19 12/31/20242,100,000 shares $433.44 thousand +14.1%N/A1.1 $0.21 12/15/20241,840,000 shares $335.98 thousand -16.4%N/A1.1 $0.18 11/30/20242,200,000 shares $455.40 thousand -7.6%N/A1.4 $0.21 11/15/20242,380,000 shares $404.60 thousand +16.7%N/A1.6 $0.17 10/31/20242,040,000 shares $560.80 thousand -4.7%N/A2.1 $0.27 10/15/20242,140,000 shares $488.78 thousand -24.9%N/A2.2 $0.23 9/30/20242,850,000 shares $732.45 thousand -9.2%N/A3.2 $0.26 9/15/20243,140,000 shares $879.20 thousand +6.1%N/A2.7 $0.28 8/31/20242,960,000 shares $952.23 thousand -28.7%N/A2.3 $0.32 8/15/20244,150,000 shares $1.20 million +18.6%N/A2.7 $0.29 7/31/20243,500,000 shares $1.14 million -5.9%N/A1.7 $0.33 7/15/20243,720,000 shares $1.13 million +86.9%N/A1 $0.31 6/30/20241,990,000 shares $550.63 thousand +28.4%N/A0.5 $0.28 6/15/20241,550,000 shares $457.56 thousand +71.8%N/A0.4 $0.30 5/31/2024902,200 shares $295.92 thousand +49.6%N/A0.3 $0.33 5/15/2024603,000 shares $214.55 thousand +45.7%N/A0.2 $0.36 4/30/2024413,800 shares $2.14 million +24.0%N/A0.2 $5.16 4/15/2024333,600 shares $1.76 million +49.6%N/A1 $5.27 3/31/2024223,000 shares $1.39 million +8.1%N/A0.7 $6.22 3/15/2024206,300 shares $1.22 million +28.8%N/A0.8 $5.93 2/29/2024160,200 shares $842.65 thousand -13.6%N/A0.6 $5.26 2/15/2024185,400 shares $927 thousand +43.5%N/A0.8 $5.00 1/31/2024129,200 shares $587.86 thousand -5.6%N/A0.6 $4.55 1/15/2024136,900 shares $736.52 thousand -22.6%N/A0.6 $5.38 12/31/2023176,800 shares $926.43 thousand +2.4%N/A0.9 $5.24 12/15/2023172,600 shares $802.59 thousand -24.4%N/A0.7 $4.65 11/30/2023228,300 shares $755.67 thousand -13.9%N/A0.6 $3.31 11/15/2023265,200 shares $766.43 thousand -17.3%N/A0.7 $2.89Bank of America Says Gold Could Hit $4,000. Here How to Get Paid (Ad)“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist believed — until he found a little-known $15 gold ETF that’s now paying up to 64% annually in monthly cash. No mining stocks. No futures. Just steady income from an asset that used to pay nothing.See the gold income fund paying 64% annually 10/31/2023320,600 shares $952.18 thousand +43.2%N/A0.9 $2.97 10/15/2023223,900 shares $801.56 thousand -38.2%N/A0.6 $3.58 9/30/2023362,100 shares $1.42 million -14.0%N/A0.9 $3.91 9/15/2023421,100 shares $1.83 million +661.5%N/A1.2 $4.35 8/31/202355,300 shares $192.44 thousand -19.5%N/A0.3 $3.48 8/15/202368,700 shares $245.95 thousand -67.0%N/A0.4 $3.58 7/31/2023208,100 shares $670.08 thousand -62.3%N/A1.1 $3.22 7/15/2023552,200 shares $1.69 million -0.1%N/A3.4 $3.06 6/30/2023552,600 shares $2.27 million +23.4%N/A4.2 $4.11 6/15/2023447,700 shares $1.34 million +56.8%N/A3.9 $2.99 5/31/2023285,500 shares $733.74 thousand +1,513.0%N/A3.7 $2.57 5/15/202317,700 shares $46.20 thousand -31.4%N/A0.5 $2.61 4/30/202325,800 shares $61.92 thousand +27.1%N/A0.7 $2.40 4/15/202320,300 shares $48.52 thousand +178.1%N/A0.6 $2.39 3/31/20237,300 shares $14.67 thousand -29.1%N/A0.2 $2.01 3/15/202310,300 shares $21.01 thousand -32.2%N/A0.3 $2.04 2/28/202315,200 shares $36.18 thousand +22.6%N/A0.5 $2.38 2/15/202312,400 shares $30.26 thousand +21.6%N/A0.4 $2.44 1/31/202310,200 shares $29.07 thousand -21.5%N/A0.3 $2.85 1/15/202313,000 shares $36.01 thousand -29.7%N/A0.2 $2.77 12/30/202218,500 shares $58.09 thousand +44.5%N/A0.3 $3.14 12/15/202212,800 shares $34.94 thousand -41.6%N/A0.2 $2.73 11/30/202221,900 shares $76.87 thousand +0.5%N/A0.3 $3.51 11/15/202221,800 shares $85.02 thousand No ChangeN/A0.3 $3.90 10/31/202221,800 shares $102.24 thousand -27.6%N/A0.3 $4.69 10/15/202230,100 shares $144.48 thousand -16.4%N/A0.9 $4.80 9/30/202236,000 shares $180.36 thousand -45.4%N/A1 $5.01 9/15/202265,900 shares $392.76 thousand -25.5%N/A1.6 $5.96 8/31/202288,400 shares $511.84 thousand -18.8%N/A1.4 $5.79 8/15/2022108,800 shares $683.26 thousand -22.6%N/A1.6 $6.28 7/31/2022140,600 shares $912.49 thousand -44.2%N/A1.9 $6.49 7/15/2022252,000 shares $1.43 million -17.5%N/A2.7 $5.69 6/30/2022305,300 shares $1.72 million +13.6%N/A1.2 $5.65 6/15/2022268,700 shares $1.35 million -38.5%N/A1 $5.02 5/31/2022437,000 shares $2.34 million +5.1%N/A1.9 $5.35 5/15/2022415,800 shares $2.03 million +10.7%N/A1.8 $4.88 4/30/2022375,600 shares $2.12 million +50.0%N/A1.7 $5.65 4/15/2022250,400 shares $1.88 million +224.4%3.9%1.2 $7.51 3/31/202277,200 shares $310.34 thousand +19.0%0.9%0.5 $4.02 3/15/202264,900 shares $262.85 thousand -44.8%0.7%1.5 $4.05 2/28/2022117,500 shares $572.23 thousand +36.3%1.2%2.4 $4.87 2/15/202286,200 shares $387.90 thousand +9.1%0.9%1.6 $4.50 1/31/202279,000 shares $323.11 thousand +5.6%0.8%1.3 $4.09 1/15/202274,800 shares $295.46 thousand +4.0%0.8%1.2 $3.95 12/31/202171,900 shares $313.48 thousand -5.8%0.8%1.2 $4.36 12/15/202176,300 shares $334.19 thousand -1.0%0.8%1.4 $4.38 11/30/202177,100 shares $431.76 thousand +2.5%0.8%1.4 $5.60 11/15/202175,200 shares $539.94 thousand -51.4%0.9%1.5 $7.18 10/29/2021154,600 shares $1.13 million -3.6%1.8%3.3 $7.30 10/15/2021160,400 shares $1.26 million -20.9%1.9%3.4 $7.85Bank of America Says Gold Could Hit $4,000. Here How to Get Paid (Ad)“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist believed — until he found a little-known $15 gold ETF that’s now paying up to 64% annually in monthly cash. No mining stocks. No futures. Just steady income from an asset that used to pay nothing.See the gold income fund paying 64% annually 9/30/2021202,700 shares $1.85 million -0.3%2.3%4.2 $9.12 9/15/2021203,300 shares $1.68 million -3.1%2.4%2.9 $8.28 8/31/2021209,700 shares $1.50 million -11.0%2.4%2.5 $7.14 8/13/2021235,700 shares $1.64 million +1.3%2.7%2.1 $6.94 7/30/2021232,700 shares $1.50 million -2.8%2.7%1.9 $6.44 7/15/2021239,400 shares $1.78 million +0.3%2.8%1.9 $7.45 6/30/2021238,700 shares $1.92 million -43.6%2.8%1.8 $8.03 6/15/2021423,100 shares $3.88 million +17.9%4.9%3.6 $9.17 5/28/2021358,900 shares $2.58 million -13.2%4.1%3.4 $7.18 5/14/2021413,600 shares $3.09 million +14.1%4.8%4.6 $7.46 4/30/2021362,500 shares $3.69 million +10.9%4.4%2.4 $10.18 4/15/2021327,000 shares $3.56 million +4.1%3.9%2.1 $10.89 3/31/2021314,200 shares $3.51 million +11.3%3.8%2.1 $11.17 3/15/2021282,300 shares $3.95 million +15.4%3.4%1.8 $13.98 2/26/2021244,600 shares $3.42 million +73.6%3.1%1.3 $14.00 2/12/2021140,900 shares $1.86 million -1.4%1.8%0.7 $13.19 1/29/2021142,900 shares $1.53 million +9.3%1.8%1.1 $10.68 1/15/2021130,800 shares $1.43 million No Change1.6%1.1 $10.96 LYRA Short Interest - Frequently Asked Questions What is Lyra Therapeutics' current short interest? Short interest is the volume of Lyra Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 123,900 shares of LYRA short. 7.74% of Lyra Therapeutics' shares are currently sold short. Learn More on Lyra Therapeutics' current short interest. What is a good short interest percentage for Lyra Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.74% of Lyra Therapeutics' floating shares are currently sold short. Is Lyra Therapeutics' short interest increasing or decreasing? Lyra Therapeutics saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 123,900 shares, an increase of 8.9% from the previous total of 113,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lyra Therapeutics' float size? Lyra Therapeutics currently has issued a total of 1,325,000 shares. Some of Lyra Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lyra Therapeutics currently has a public float of 1,600,000 shares. How does Lyra Therapeutics' short interest compare to its competitors? 7.74% of Lyra Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Lyra Therapeutics: Daxor Corporation (0.60%), Vivos Therapeutics, Inc. (1.56%), Nephros Inc. (0.04%), Modular Medical, Inc. (0.28%), Precision Optics Corp. (1.11%), NeuroOne Medical Technologies Corporation (0.23%), PolyPid Ltd. (2.70%), Envoy Medical, Inc. (1.08%), DarioHealth Corp. (7.85%), Femasys Inc. (0.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Lyra Therapeutics stock? Short selling LYRA is an investing strategy that aims to generate trading profit from Lyra Therapeutics as its price is falling. LYRA shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lyra Therapeutics? A short squeeze for Lyra Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LYRA, which in turn drives the price of the stock up even further. How often is Lyra Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LYRA, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Daxor Short Interest Data Vivos Therapeutics Short Interest Data Nephros Short Interest Data Modular Medical Short Interest Data Precision Optics Short Interest Data NeuroOne Medical Technologies Short Interest Data PolyPid Short Interest Data Envoy Medical Short Interest Data DarioHealth Short Interest Data Femasys Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LYRA) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s Little-Known Succession PlanYou could miss out on millions buying a house - even if prices rise Joel Litman is a millionaire member of ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LYRA Stock Alerts